Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host
- PMID: 27794505
- DOI: 10.1016/j.parint.2016.10.020
Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host
Abstract
Characterizing the clinical, immunological and parasitological features associated with visceral leishmaniasis is complex. It involves recording in real time and integrating quantitative multi-parametric data sets from parasite infected host tissues. Although several models have been used, hamsters are considered the bona fide experimental model for Leishmania donovani studies. To study visceral leishmaniasis in hamsters we generated virulent transgenic L. donovani that stably express a reporter luciferase protein. Two complementary methodologies were combined to follow the infectious process: in vivo imaging using luciferase-expressing Leishmania and real time RT-PCR to quantify both Leishmania and host transcripts. This approach allows us: i) to assess the clinical outcome of visceral leishmaniasis by individual monitoring of hamster weight, ii) to follow the parasite load in several organs by real time analysis of the bioluminescence in vivo and through real time quantitative PCR analysis of amastigote parasite transcript abundance ex vivo, iii) to evaluate the immunological responses triggered by the infection by quantifying hamster transcripts on the same samples and iv) to limit the number of hamsters selected for further analysis. The overall data highlight a correlation between the transcriptional cytokine signatures of hamster affected tissues and the amastigote burden fluctuations, thus providing new insights into the immunopathological process driven by L. donovani in the tissues of mammalian hosts. Finally, they suggest organ-specific immune responses.
Keywords: Bioluminescence; Hamsters; Luciferase; Virulent transgenic Leishmania donovani; Visceral leishmaniasis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
A combined luciferase imaging and reverse transcription polymerase chain reaction assay for the study of Leishmania amastigote burden and correlated mouse tissue transcript fluctuations.Cell Microbiol. 2011 Jan;13(1):81-91. doi: 10.1111/j.1462-5822.2010.01521.x. Epub 2010 Sep 16. Cell Microbiol. 2011. PMID: 20846338
-
Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes.BMC Immunol. 2014 Nov 26;15:38. doi: 10.1186/s12865-014-0038-z. BMC Immunol. 2014. PMID: 25424735 Free PMC article.
-
New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence.PLoS Negl Trop Dis. 2017 Sep 25;11(9):e0005924. doi: 10.1371/journal.pntd.0005924. eCollection 2017 Sep. PLoS Negl Trop Dis. 2017. PMID: 28945751 Free PMC article.
-
Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis.Trends Parasitol. 2004 Nov;20(11):524-30. doi: 10.1016/j.pt.2004.08.009. Trends Parasitol. 2004. PMID: 15471704 Review.
-
Determinants for the development of visceral leishmaniasis disease.PLoS Pathog. 2013 Jan;9(1):e1003053. doi: 10.1371/journal.ppat.1003053. Epub 2013 Jan 3. PLoS Pathog. 2013. PMID: 23300451 Free PMC article. Review.
Cited by
-
Bioprospecting marine actinomycetes for antileishmanial drugs: current perspectives and future prospects.Heliyon. 2021 Aug 2;7(8):e07710. doi: 10.1016/j.heliyon.2021.e07710. eCollection 2021 Aug. Heliyon. 2021. PMID: 34409179 Free PMC article. Review.
-
The relationship between fleas and small mammals in households of the Western Yunnan Province, China.Sci Rep. 2020 Oct 7;10(1):16705. doi: 10.1038/s41598-020-73690-0. Sci Rep. 2020. PMID: 33028907 Free PMC article.
-
Establishment, optimisation and quantitation of a bioluminescent murine infection model of visceral leishmaniasis for systematic vaccine screening.Sci Rep. 2020 Mar 13;10(1):4689. doi: 10.1038/s41598-020-61662-3. Sci Rep. 2020. PMID: 32170135 Free PMC article.
-
Murine infection with bioluminescent Leishmania infantum axenic amastigotes applied to drug discovery.Sci Rep. 2019 Dec 12;9(1):18989. doi: 10.1038/s41598-019-55474-3. Sci Rep. 2019. PMID: 31831809 Free PMC article.
-
A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery.PLoS Negl Trop Dis. 2019 Feb 14;13(2):e0007133. doi: 10.1371/journal.pntd.0007133. eCollection 2019 Feb. PLoS Negl Trop Dis. 2019. PMID: 30763330 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources